Hemosiderosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[IPH]] was first described as "brown lung induration" by Rudolf Virchow in 1864 in patients after their death. Wilhelm Ceelen gave a more detailed description of the condition after [[autopsies]] revealed large amounts of [[hemosiderin]] in 2 children in 1931. In 1944, the antemortem [[diagnosis]] was made by Waldenstrom. | |||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 05:27, 28 September 2020
|
Hemosiderosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemosiderosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Hemosiderosis historical perspective |
|
Risk calculators and risk factors for Hemosiderosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
IPH was first described as "brown lung induration" by Rudolf Virchow in 1864 in patients after their death. Wilhelm Ceelen gave a more detailed description of the condition after autopsies revealed large amounts of hemosiderin in 2 children in 1931. In 1944, the antemortem diagnosis was made by Waldenstrom.
Historical Perspective
- IPH was first described as "brown lung induration" by Rudolf Virchow in 1864 in patients after their death.[1]
- Wilhelm Ceelen gave a more detailed description of the condition after autopsies revealed large amounts of hemosiderin in 2 children in 1931.
- In 1944, the antemortem diagnosis was made by Waldenstrom